Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Luxembourg, Apr 05, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) ("Company" or "Moolec"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded that Moolec's GLA safflower plants pose no greater plant pest risk than non-genetically engineered safflower plants according to regulation found at 7 CFR part 340. To access the Regulatory Status Review ("RSR") response from USDA-APHIS, click here. https://pr.report/piWafISN Moolec's CEO and co-founder Gaston Paladini stated, "This important milestone reinforces our go-to-market path and validates our proposed regulatory strategy. Also, it complements the FDA's food safety reviews and approvals already obtained for our GLA safflower oil (GLASO)." He finished by declaring, "The green light from USDA-APHIS bolsters the idea of the safe use of Molecular Farming technology to improve nutritional profile for end food products. Moolec is very excited that its innovative food ingredients are a key part of the bioeconomy."
Martin Salinas, Chief of Technology and co-founder of Moolec, expressed, "This will greatly increase the efficiency of our operations, including raw material procurement, downstream crushing, and processing. We will no longer need USDA-APHIS permits to import, move interstate or grow these plants in the field in the United States." He concluded, "We are positive that this achievement paves the way for our upcoming regulatory reviews in our pipeline."
According to USDA-APHIS regulation found at 7 CFR part 340, developers may submit a request for a RSR when they believe a genetically engineered ("GE") plant is not subject to the regulation. APHIS reviews the GE plant and considers whether it might pose an increased plant pest risk compared to its non-GE comparator. If APHIS does not identify a greater pest risk relative to the comparator, the GE plant is not subject to this regulation. Regulation 7 CFR part 340 governs the importation, interstate movement, and the environmental release of certain organisms that have been modified or produced by genetic engineering.
About Moolec Science SA
Moolec is a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The Company's technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company's product portfolio and pipeline leverage the agronomic efficiency of broadly used target crops, like safflower, soybean, and pea. Moolec has a growing international patent portfolio (23, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit www.moolecscience.com.
Forward-Looking Statements
This press release contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec Science S.A. ("Moolec") are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in the Form F-1 Registration Statement filed with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.
Contact Information Catalina Jones Chief of Staff & Sustainability comms@moolecscience.com
Martin Taraciuk Investor Relations ir@moolecscience.com
Michael Bowen ICR, LLC moolecir@icrinc.com
Related Files Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product https://cdn.newswire.com/files/x/03/7c/bcbadb44190484d6da7107cf3b7c.pdf
SOURCE: Moolec Science
Source: Moolec Science SA Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Approval in Principle (AiP) for the Basic Design of a Large Ammonia-Fueled Ammonia Carrier Obtained from Classification Society Mar 14, 2025 18:37 JST
|  Toyota Launches All-New Crown Estate in Japan Mar 14, 2025 17:22 JST
|  Hokkaido Electric Power Corporation and Mitsubishi Corporation Establish a Joint Venture "Hokkaido Renewable Energy Aggregation Co., Ltd." Mar 13, 2025 13:26 JST
|  Lexus Presents the World Premiere of the New "RZ" Mar 12, 2025 17:45 JST
|  MHIET Achieves Rated Operation of a 6-Cylinder 500kW-class Hydrogen Engine Generator Set Mar 12, 2025 14:11 JST
|  MOL and Fujitsu leverage AI for efficient crew replacement planning Mar 12, 2025 13:53 JST
|  TANAKA PRECIOUS METAL TECHNOLOGIES Develops Miniaturized Micro Profile, a Next-Generation Contact tape for Fifth-Generation Signal Relays Mar 12, 2025 11:00 JST
|  JCB Now Available on Google Play in Thailand, Indonesia, Vietnam, Philippines, and Hong Kong Mar 12, 2025 11:00 JST
|  JCB Announced Premier Sponsorship for the 10th Edition of Sakura 2025 at Singapore's Gardens by the Bay Mar 11, 2025 18:00 JST
|  Hitachi Energy invests additional $250 million USD to address global transformer shortage Mar 11, 2025 17:49 JST
|  Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time Mar 10, 2025 20:24 JST
|  CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI Mar 10, 2025 12:10 JST
|  Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels Mar 07, 2025 16:24 JST
|  NEC improves the energy efficiency and floor space density of 5G Mobile Core systems Mar 06, 2025 13:20 JST
|  Unmanned Aerial Vehicles Being Developed by MHI Used in Demonstration of Automated Transport and Unloading of Heavy Cargo in Disaster Areas Mar 05, 2025 16:11 JST
|  Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan Mar 05, 2025 09:09 JST
|  MHI-MS Completes Domestic Development of Vehicle Transport Robot Mar 04, 2025 19:39 JST
|  Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia Mar 04, 2025 17:22 JST
|  Prideone Entertainment announces concept for post-war film to mark 80th anniversary of the end of World War II Mar 04, 2025 16:00 JST
|  NTT and DOCOMO Successfully Demonstrates On-Demand Unified Control of Computing Services Through Network and Service Integration Mar 03, 2025 20:25 JST
|
More Latest Release >>
|